Nkarta to Participate in an Upcoming Investor Conference

Rhea-AI Summary

Nkarta (Nasdaq: NKTX), a company focused on engineered natural killer (NK) cell therapies, has announced its upcoming participation in the Stifel 2024 Healthcare Conference. The company will participate in a fireside chat scheduled for November 19, 2024, at 10:55 a.m. ET. The event will be webcast live on Nkarta's website investor section, with a replay available for approximately 90 days afterward.

News Market Reaction – NKTX

-10.03%

-10.03% Session move

In the trading session that priced this news, NKTX declined 10.03%, reflecting a significant negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SOUTH SAN FRANCISCO, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its participation in the following investor conference:

Stifel 2024 Healthcare Conference
November 19, 2024
10:55 a.m. ET – fireside chat

A simultaneous webcast of the event will be available on the Investors section of Nkarta’s website, www.nkartatx.com, and a replay will be archived on the website for approximately 90 days.

About Nkarta
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off-the-shelf natural killer (NK) cell therapies. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies and CRISPR-based genome engineering capabilities, Nkarta is building a pipeline of future cell therapies engineered for deep therapeutic activity and intended for broad access in the outpatient treatment setting. For more information, please visit the company’s website at www.nkartatx.com.

Nkarta Media/Investor Contact:
Greg Mann
Nkarta, Inc.
gmann@nkartatx.com

FAQ

When is Nkarta (NKTX) presenting at the Stifel 2024 Healthcare Conference?

Nkarta (NKTX) is scheduled to present at the Stifel 2024 Healthcare Conference on November 19, 2024, at 10:55 a.m. ET.

How can I watch Nkarta's (NKTX) presentation at the Stifel Healthcare Conference?

The presentation can be viewed through a live webcast on Nkarta's website (www.nkartatx.com) in the Investors section. A replay will be available for approximately 90 days afterward.

What type of therapies does Nkarta (NKTX) develop?

Nkarta (NKTX) develops engineered natural killer (NK) cell therapies as indicated in the press release.